CannAssure Therapeutics

Medical Cannabis Products

Health Tech & Life Sciences
Active
Public Ashdod, Israel Founded 2016
Last updated 2026-06-18
Total raised
$3.4M
Last: Grant 2020-08
Stage
Public
Founded
2016
Headcount
8
HQ
Ashdod, Israel
Sector
Health Tech & Life Sciences

About

Cannassure develops and commercializes a wide range of effective, high-quality, affordable medical cannabis products and pharmaceutical cannabinoid medicines designed to enhance treatment and improve the quality of life for people worldwide. The company ensures the highest standards by facilitating a holistic integrated production system, including a clean and controlled and advanced indoor aeroponic grow facility and an extraction and processing facility, along with scientifically advanced research and development. Cannassure operates in accordance with IMC-GAP standards, testing both its unprocessed cultivated cannabis and its manufactured products at different stages of production to ensuring purity, effectiveness, stability, and consistency for the duration of the products shelf life. Cannasure is a spinoff of food manufacturer Solbar Food Technologies, with 60 years of applied industrial expertise and know-how. Solbar is the majority shareholder in the company.

Funding history · 1 round · $3.4M total

2020-08

Q&A

What is CannAssure Therapeutics' primary focus?
CannAssure Therapeutics develops and commercializes medical cannabis products and pharmaceutical cannabinoid medicines.
When was CannAssure Therapeutics founded?
CannAssure Therapeutics was founded in January 2016.
What is the current employee count for CannAssure Therapeutics?
CannAssure Therapeutics has 1-10 employees.
What is the total funding raised by CannAssure Therapeutics to date?
CannAssure Therapeutics has raised a total of $3,435,000 USD.
When did CannAssure Therapeutics last receive funding and from whom?
In August 2020, CannAssure Therapeutics received a Grant from Israel Innovation Authority.
What is CannAssure Therapeutics' current operational status?
CannAssure Therapeutics is active and has been public on TASE since December 2018.
Who is the majority shareholder of CannAssure Therapeutics?
Solbar Food Technologies, a food manufacturer, is the majority shareholder in CannAssure Therapeutics.
Where is CannAssure Therapeutics headquartered?
CannAssure Therapeutics is headquartered in Ashdod, Israel.

Team · 1

Founder · Founder & Board Member
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentMedical Cannabis
Technologies
BiologicalsHerbals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcarePatients
Business model
B2B2CB2B

Highlights

1 Patents

Tags

pharmaceuticalsseedscannabismedical-productsmedical-cannabisdrug-deliverywomen-healthpatientsindoor-farmingtopical-treatmentdermatologyoral-drugsanti-inflammatory
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)